Proactive news snapshot: IXICO, Motif Bio, BATM Advanced Communications...

A glance at some of the day's highlights from the Proactive Investors newswire


IXICO PLC (LON:IXI) said its performance for the current year will be “materially ahead” of market expectations with the company breaking even in the final six months. 

Motif Bio PLC (LON:MTFB) is assessing the potential of lead drug iclaprim as a combatant for the life-threatening infection listeria. 

BATM Advanced Communications Limited (LON:BVC) has reported an increase in its underlying earnings for the first half of 2019 and expects to record good growth for the full-year as it gains increasing commercial traction in two key areas. 

Highlands Natural Resources PLC (LON:HNR) has decided to focus its attention on growing its recently-launched cannabis business following a strong start to trading. 

Malcolm Pye, the chief executive officer of Benchmark Holdings PLC (LON:BMK), has notified the board of his decision to step down on 30 November.

Antenna maker MTI Wireless Edge Limited (LON:MWE) has hinted it could beat full-year expectations after posting a 67% surge in first-half profits.

South African miner BlueRock Diamonds PLC (LON:BRD) has sold a fifth stone from the Kareevlei mine for more than US$50,000.

Redx Pharma PLC (LON:REDX) has been told it can up the dose of its lead cancer drug, RXC004, after it successfully navigated the first part of its early-stage trial.  

Mkango Resources Ltd (LON:MKA)(CVE:MKA) has confirmed that a recently shipped 60 tonne bulk rock sample taken from the Songwe Hill rare earths project has now arrived into Fremantle Port in Western Australia. 

Adamas Finance Asia Limited’s (LON:ADAM) portfolio firm, Hong Kong Mining Holdings Limited (HKMH), is expecting to restart operations in the second half of this year.  

AfriTin Mining Ltd (LON:ATM) has produced its tin concentrate from the Uis tin mine in Namibia. Tin production comes soon after the company announced the completion of the Phase 1 pilot plant on 26 July 2019 and that hot and cold commissioning were nearing completion.

Scancell Holdings PLC (LON:SCLP) is to begin the UK arm of the phase II trial of its flagship skin cancer treatment immediately. The trial is testing the safety and efficacy of SCIB1 in 25 metastatic melanoma patients who are also receiving Merck’s blockbuster checkpoint inhibitor Keytruda.

Alternative fuels group Quadrise International PLC (LON:QUAD) expects to confirm funding plans by the end of the month.

Thor Mining PLC (LON:THR) shares advanced on Monday after the firm reported more positive drilling results from the Big Sandy project in Arizona, USA.

Premier African Minerals Limited (LON:PREM) expects the electrification of its RHA tungsten mine to be completed by the end of November following talks with Zimbabwe's electricity company ZESA.

Georgina Energy offers investors exposure to the increasingly supply-constrained helium -- an important industrial gas with applications in medical, industrial and technology industries --- according to Proactive Research ahead of the company's initial public offering. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zoetic International PLC named herein, including the promotion by the Company of Zoetic International PLC in any Content on the Site, the...



Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 8 hours ago

3 min read